Literature DB >> 7876077

Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes.

M Ridderstråle1, E Degerman, H Tornqvist.   

Abstract

Insulin receptor substrate-1 (IRS-1) is tyrosine-phosphorylated in response to insulin resulting in association with and activation of phosphatidylinositol 3-kinase (PI 3-kinase), thereby initiating some of the effects of insulin. We have recently shown that the insulin-like effects of growth hormone (GH) in adipocytes can be inhibited by the selective PI 3-kinase inhibitor wortmannin (Ridderstråle, M., and Tornqvist, H. (1994) Biochem. Biophys. Res. Commun. 203, 306-310), suggesting a similar role for PI 3-kinase in GH action. Here we show that IRS-1 is tyrosine-phosphorylated in a time- and dose-dependent manner in response to GH in primary rat adipocytes. This phosphorylation coincided with the extent of interaction between IRS-1 and the 85-kDa subunit of PI 3-kinase as evidenced by coimmunoprecipitation. Stimulation with 23 nM GH increased the PI 3-kinase activity associated with IRS1 4-fold. Our data suggest that GH-induced tyrosine phosphorylation of IRS-1 and the subsequent docking of PI 3-kinase are important postreceptor events in GH action. The mechanism for the phosphorylation of IRS-1 induced by GH is unknown, but involvement of JAK2, the only known GH receptor-associated tyrosine kinase, seems possible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876077     DOI: 10.1074/jbc.270.8.3471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.

Authors:  S J MacKenzie; S J Yarwood; A H Peden; G B Bolger; R G Vernon; M D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 2.  Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling.

Authors:  David N Boone; Adrian V Lee
Journal:  Crit Rev Oncog       Date:  2012

3.  Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.

Authors:  H Miki; T Yamauchi; R Suzuki; K Komeda; A Tsuchida; N Kubota; Y Terauchi; J Kamon; Y Kaburagi; J Matsui; Y Akanuma; R Nagai; S Kimura; K Tobe; T Kadowaki
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  Chromium (D-phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities.

Authors:  Machender Reddy Kandadi; M K Unnikrishnan; Ajaya Kumar Sankara Warrier; Min Du; Jun Ren; Nair Sreejayan
Journal:  J Inorg Biochem       Date:  2011-01       Impact factor: 4.155

5.  Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function.

Authors:  H Ueno; E Kondo; R Yamamoto-Honda; K Tobe; T Nakamoto; K Sasaki; K Mitani; A Furusaka; T Tanaka; Y Tsujimoto; T Kadowaki; H Hirai
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

6.  Specific inhibition of the cGMP-inhibited cAMP phosphodiesterase blocks the insulin-like antilipolytic effect of growth hormone in rat adipocytes.

Authors:  H Eriksson; H Tornqvist
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

7.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

Review 8.  Insulin receptor substrates (IRSs) and breast tumorigenesis.

Authors:  Bonita Tak-Yee Chan; Adrian V Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-22       Impact factor: 2.673

9.  Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I.

Authors:  Guolian Li; Juan-Pablo Del Rincon; Linda A Jahn; Yangsong Wu; Bruce Gaylinn; Michael O Thorner; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

Review 10.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.